Clinical trials: System Validation, open to volunteers
Cerebral Palsy (CP)
Feasibility and Discriminant Validity of Monitoring Movement Behavior of Adolescents With Cerebral Palsy
A new artificial intelligence network has been developed to monitor real-world daytime and nighttime movement behavior of adolescents with cerebral palsy (CP).
- Trial name
- NCT06090383
- Where
- Denmark
- Volunteers
- 25 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Cystic Fibrosis
Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)
Development, validation and evaluation of a new multimodal questionnaire to assess and quantify the abdominal involvement in patients with the inherited life shortening multi-organ disease Cystic fibrosis.
- Trial name
- CFAbd-Score (NCT03052283)
- Testing
- Questionnaire Patient Reported Outcome Measure (PROM)
- Where
- 2 sites in Germany
- Volunteers
- 2,000 people, healthy volunteers welcome
- Sponsor
- Medizinische Hochschule Brandenburg Theodor Fontane
Toileting-Related Falls, Fall Risk
Integrated Prevention, Treatment, and Rehabilitation for Toileting-Related Falls
Toileting-related falls may result from a combination of urinary symptoms, impaired gait and balance, reduced muscle strength, cognitive or emotional problems, and unsafe environmental conditions.
- Trial name
- NCT07738354
- Testing
- Individualized Multidimensional Management Program for Toileting-Related Fall Prevention
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Qing Yuan
Stroke
Virtual Reality Software for Patients With Stroke
The goal os this clinical trial is to develop and validate a gamified, fully immersive, and stroke-specific virtual reality software to improve physical disability and quality of life in patients with stroke.
- Trial name
- RESET (NCT06132399)
- Testing
- META QUEST 3 virtual reality glasses, Nintendo Switch (Nintendo Co., Ltd, Kyoto, Japan), Usual care
- Where
- 4 sites in Spain
- Volunteers
- 96 people
- Sponsor
- Universidad de Almeria
Cough, Asthma
Validation of the C-mo System - Cough Monitoring
The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory symptom.
- Conditions
- Cough, Asthma, Chronic Obstructive Pulmonary Disease, Gastro Esophageal Reflux
- Trial name
- C-mo_01 (NCT05989698)
- Testing
- C-mo System
- Where
- 8 sites in Portugal
- Volunteers
- 300 people
- Sponsor
- Cough Monitoring Medical Solutions
Biliary Tract Cancer (BTC)
Prospective AI-Assisted Screening of Biliary Tract Cancer Using Non-Contrast CT
Biliary tract cancer is a group of malignant tumors involving the intrahepatic bile ducts, extrahepatic bile ducts, and gallbladder.
- Trial name
- BTC-NCCT-AI (NCT07911397)
- Testing
- AI-Assisted Biliary Tract Cancer Screening Using NCCT
- Where
- China
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
Oral Cancer, AI (Artificial Intelligence)
AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients
This study aims to evaluate the validity and reliability of a novel AI-based physiotherapy evaluation system for measuring oromandibular and neck-shoulder range of motion (ROM).
- Trial name
- NCT07509619
- Where
- Taiwan
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Diffuse Midline Glioma (DMG), Glioblastoma
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
This phase I trial studies the effects and best dose of ONC206 alone or in combination with radiation therapy in treating patients with diffuse midline gliomas that is newly diagnosed or has come back (recurrent) or other…
- Conditions
- Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma, Recurrent Malignant Central Nervous System Neoplasm
- Trial name
- PNOC023 (NCT04732065)
- Testing
- ONC206, Standard of Care Radiation Therapy, Optional Proton (1H) MR spectroscopy (MRS)
- Where
- 7 sites in United States, Netherlands and 1 more
- Volunteers
- 208 people
- Sponsor
- Sabine Mueller, MD, PhD